Sr One Capital Management as of June 30, 2025
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 13 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 33.5 | $155M | 2.3M | 65.85 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 15.2 | $70M | 4.0M | 17.45 | |
| CRISPR Therapeutics Common Shares (CRSP) | 11.1 | $51M | 1.0M | 48.64 | |
| Zenas BioPharma Common Stock (ZBIO) | 10.3 | $48M | 4.9M | 9.69 | |
| ORIC Pharmaceuticals Common Stock (ORIC) | 9.9 | $46M | 4.5M | 10.15 | |
| Mineralys Therapeutics Common Stock (MLYS) | 9.2 | $42M | 3.1M | 13.53 | |
| Design Therapeutics Common Stock (DSGN) | 4.8 | $22M | 6.5M | 3.37 | |
| Oculis Holding Ordinary Shares (OCS) | 1.4 | $6.3M | 323k | 19.41 | |
| Alumis Common Stock (ALMS) | 1.3 | $5.9M | 2.0M | 3.00 | |
| Nkarta Common Stock (NKTX) | 1.2 | $5.5M | 3.3M | 1.66 | |
| Oruka Therapeutics Common Stock (ORKA) | 1.0 | $4.8M | 430k | 11.21 | |
| KALA Bio Common Stock (KALA) | 0.6 | $2.9M | 599k | 4.76 | |
| enGene Holdings Common Shares (ENGN) | 0.6 | $2.7M | 748k | 3.64 |
